The purpose of this study is to identify if there is a relationship between multiple sclerosis disease-modifying therapy exposure, immunodeficiencies, and infection risk in subjects living with MS.
The purpose of this study is to identify if there is a relationship between multiple sclerosis disease-modifying therapy exposure, immunodeficiencies, and infection risk in subjects living with MS. By understanding this relationship future studies can be designed to create a model of immunosenescence in multiple sclerosis, which could help healthcare providers to predict and assess health risks. Preventative strategies can then be tested to look for ways to prevent these immune-related risks.
Study Type
OBSERVATIONAL
Enrollment
1,500
There are no interventions associated with the study.
Advanced Neurosciences Institute
Franklin, Tennessee, United States
Immunoglobulin Levels
IgG, IgA, IgM
Time frame: 1 year
Infections
Serious and non-serious
Time frame: 1 year
Immune-mediated conditions
Serious and non-serious
Time frame: 1 year
Malignant and pre-malignant conditions
Serious and non-serious
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.